Comparison by Transoesophageal Assessement of Systolic Right Ventricle Function Measures in Perioperative Care of Pulmonary Transplant.

Overview

The aim of the study is to describe the early adaptation of the right ventricle assessed by echocardiography to change of pulmonary circulation secondary to pulmonary transplantation. Secondary objectives include change of haemodynamics measured by transpulmonary thermodilution and evolution of right heart function in terms of primary graft dysfunction grading.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Basic Science
    • Masking: None (Open Label)
  • Study Primary Completion Date: February 20, 2018

Interventions

  • Procedure: transoesophageal echocardiography

Arms, Groups and Cohorts

  • Experimental: All patient
    • Only one arm has been specified for the protocol. This arm included all study patient (33) for which the intervention is to be administered

Clinical Trial Outcome Measures

Primary Measures

  • Transesophageal echocardiographic assessment for comparision of right ventricle free-wall strain rate in perioperative care of bipulmonary transplantation
    • Time Frame: Outcome is measured 3 times : after induction of general anesthesia, before surgical incision, after throacic closure and 6 to 12 hours postoperative.
  • Transesophageal echocardiographic assessment for comparision of right ventricle isovolumic acceleration in perioperative care of bipulmonary transplantation
    • Time Frame: utcome is measured 3 times : after induction of general anesthesia, before surgical incision, after throacic closure and 6 to 12 hours postoperative.

Participating in This Clinical Trial

Inclusion Criteria

  • Adult (over 18 years) – Patient affiliated to a social protection scheme insurance – Patient was informed of the study and w gave their consent – Patient on the lung transplant list – Patient eligible for a pulmonary transplantation after decision of a multidisciplinary team – Patients with chronic lung disease with parenchymal dysfunctions (Chronic obstructive pulmonary disease or COPD, alpha-1 antitrypsin deficiency, cystic fibrosis, pulmonary fibrosis, bronchiolitis obliterans organizing pneumonia or BOOP) Exclusion Criteria:

d

  • Minor patients – Patient under judicial protection, under guardianship – Patient in exclusion period (determined by a previous study or in progress) – Patient participating in parallel in another clinical trial that may interfere with the results of the study – Inability to give informed patient information (emergency, understanding difficulties, etc …) – The refusal of patient consent – The use of cardiopulmonary bypass during lung transplantation – Uni-pulmonary transplant – A transplant for idiopathic or primary pulmonary hypertension – The presence of a cons-indication for transesophageal echocardiography: o Absolute contraindications: – Abnormalities of the esophagus: stenosis, tumor, diverticulum perforation, active bleeding o Relative contraindications: – ancient cervicothoracic irradiation history (> 10 years) – recent upper gastrointestinal bleeding history – presence of esophageal varices ≥ grade II – zero cervical mobility – Reflux Esophagitis – Severe coagulation disorders – Pregnancy / Breastfeeding

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Strasbourg, France
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Gharib Ajob, MD, Principal Investigator, Strasbourg’s University Hospitals

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.